2025年2月，四川大学华西医院骨科/骨研所周宗科教授、黄石书研究员团队在SCIENCE CHINA Life Sciences上发表题为“Inhibition of KDM6B prevents osteoarthritis by blocking growth plate-like H ...

The VDH reported on May 22 that a second juvenile in the "Under 10" age range has died of COVID-19 since the pandemic began ...

Nektar Therapeutics and TrialNet, an international clinical trial network at the forefront of diabetes research, today announced a new collaboration agreement to evaluate Nektar's rezpegaldesleukin in ...

High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

The number of reported COVID cases decreased, from 189 to 162; they were at 67 in early December. Cases had fallen in April ...

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

Respiratory syncytial virus (RSV) is known to cause considerable respiratory infection-related morbidity and mortality worldwide.1,2 Estimates published in 2022 from the UK highlight the ...

Nektar Therapeutics’s NKTR share price has surged by 10.22%, which has investors questioning if this is right time to sell.

Big pharma has come under a lot of scrutiny from regulators and consumers as sentiment sours on the industry. As such, the market can be unforgiving when companies even slightly miss expectations or ...

Health Minister Datuk Seri Dzulkefly Ahmad said there was no cause for worry over the shortage of certain flu vaccines, explaining that alternatives were available and resupplies were set to arrive ...